In conclusion, our findings demonstrate that MiCU1/2 is significantly downregulated in BRCA tissues, yet exhibits high diagnostic and prognostic value for BRCA, while also being intricately linked to tumor immune regulatory mechanisms. Here, MICU1 is linked to neoplasm.